• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 1290 Show All Page 1 of 26
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1290
Glucose oxidase enzyme preparation produced by Komagataella phaffii expressing a gene encoding glucose oxidase from Aspergillus niger Pending
  1289
Protein-glutamine glutaminase enzyme preparation produced by Bacillus licheniformis expressing a gene encoding protein-glutamine glutaminase from Chryseobacterium viscerum Pending
  1288
Enzyme-modified steviol glycosides Pending
  1287
Sucrose oligoesters Pending
  1286
Brazzein preparation produced by Zea mays expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
  1285
Saccharomyces cerevisiae BY-927 expressing a gene encoding α-acetolactate decarboxylase enzyme from Acetobacter aceti Pending
  1284
Recombinant bovine lactoferrin produced by a modified strain of Komagataella phaffii Pending
  1283
Bacillus coagulans “BC99” spore preparation Pending
  1282
Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Jan 12, 2026 FDA has no questions (in PDF) (257 kB)
  1281
2'-Fucosyllactose Pending
  1280
Pleurotus pulmonarius mycelia and Chlorella vulgaris microalgae Pending
  1279
Saccharomyces cerevisiae CCTCC M2025194 Pending
  1278
Lactiplantibacillus plantarum CGMCC 6312 Pending
  1277
Autoclaved Parabacteroides goldsteinii RV-01 Jan 22, 2026 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (293 kB)
  1276
Cellulase enzyme preparation produced by Trichoderma reesei expressing a gene encoding a cellulase from Aspergillus niger Pending
  1275
6′-Sialyllactose sodium salt Pending
  1274
2'-Fucosyllactose Dec 8, 2025 FDA has no questions (in PDF) (353 kB)
  1273
Lacto-N-tetraose Pending
  1272
Lacto-N-neotetraose Pending
  1271
Short-chain fructooligosaccharides Pending
  1270
L-ergothioneine produced by Escherichia coli K-12 MG1655 expressing enzymes from Neurospora crassa and Mycolicibacterium smegmatis MC2 155 Pending
  1269
Modified-monellin preparation produced by Komagataella phaffii CBS 150005 expressing a gene encoding for a modified monellin Pending
  1268
Mycelial biomass from Rhizomucor pusillus Pending
  1267
Sunflower lecithin Pending
  1266
Wheat fiber extract from wheat (Triticumaestivum) Pending
  1265
Saccharomyces cerevisiae "BY-1532" Dec 11, 2025 FDA has no questions (in PDF) (270 kB)
  1264
Lacticaseibacillus rhamnosus CGMCC18639 Dec 9, 2025 FDA has no questions (in PDF) (268 kB)
  1263
Bacillus coagulans PTA-127366 spore preparation Pending
  1262
2'-Fucosyllactose Pending
  1261
2'-Fucosyllactose Pending
  1260
Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Nov 18, 2025 FDA has no questions (in PDF) (261 kB)
  1259
Fungal oil (≥40% arachidonic acid (ARA)) from Mortierella alpina strain TKA-1 Jan 7, 2026 FDA has no questions (in PDF) (198 kB)
  1258
Lacto-N-tetraose Pending
  1257
2'-Fucosyllactose Pending
  1256
Lemna leaf protein
   (Resubmission of GRN 1160)
Pending
  1255
Mycelial biomass of Fusarium compactum CGMCC 41312 (fungal protein) Nov 18, 2025 FDA has no questions (in PDF) (251 kB)
  1254
Bovine plasma protein preparation Pending
  1253
Lycopene preparation produced by Saccharomyces cerevisiae JZL03 Pending
  1252
Saccharomyces cerevisiae "BY-1568" Sep 23, 2025 FDA has no questions (in PDF) (162 kB)
  1251
Saccharomyces cerevisiae expressing a gene encoding a cysteine-thiol lyase from Staphylococcus hominis (S. cerevisiae "OYR-290") Sep 23, 2025 FDA has no questions (in PDF) (164 kB)
  1250
Alternansucrase enzyme preparation produced by Escherichia coli expressing the gene encoding alternansucrase from Leuconostoc mesenteroides Pending
  1249
Ovalbumin produced by Trichoderma reesei ATCC 13631 Sep 16, 2025 FDA has no questions (in PDF) (206 kB)
  1248
Yeast biomass produced by Kluyveromyces marxianus CCTCC M 20211265 Sep 23, 2025 FDA has no questions (in PDF) (236 kB)
  1247
β-Lactoglobulin produced by Kluyveromyces lactis CCTCC M20241460 Sep 19, 2025 FDA has no questions (in PDF) (209 kB)
  1246
Saccharomyces cerevisiae BY-1248 Sep 22, 2025 FDA has no questions (in PDF) (172 kB)
  1245
Lactiplantibacillus plantarum DSM 21379 Aug 5, 2025 FDA has no questions (in PDF) (173 kB)
  1244
Lactiplantibacillus plantarum DSM 21380 Aug 5, 2025 FDA has no questions (in PDF) (174 kB)
  1243
Bacillus coagulans M2017813 spore preparation Aug 21, 2025 FDA has no questions (in PDF) (205 kB)
  1242
Short-chain fructooligosaccharides Jul 14, 2025 FDA has no questions (in PDF) (94 kB)
  1241
β-lactoglobulin produced by Aspergillus oryzae Sep 16, 2025 FDA has no questions (in PDF) (253 kB)

Show All 

jump to page of 26 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-